NTI — Neurotech International Cashflow Statement
0.000.00%
- AU$29.18m
- AU$23.22m
- AU$3.34m
Annual cashflow statement for Neurotech International, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | AAS | AAS | AAS | AAS | AAS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | 0.002 | 0 | 0 | 0.06 | 0.158 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | -0.683 | -2.32 | -2.96 | -6.32 | -4.6 |
Capital Expenditures | — | — | -0.003 | 0 | — |
Purchase of Fixed Assets | |||||
Cash from Investing Activities | — | — | -0.003 | 0 | — |
Financing Cash Flow Items | 0 | -0.443 | 0 | — | 0 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.221 | 7.13 | 0.026 | 9.45 | 11.2 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.462 | 4.82 | -2.93 | 3.13 | 6.6 |